Articles published by GlobeNewswire
Anaptys Announces Intent to Separate Biopharma Operations from Substantial Royalty Assets by Year-end 2026
September 29, 2025
From AnaptysBio, Inc.
Via GlobeNewswire
Tickers
ANAB
Anaptys to Provide Overview of ANB033, a CD122 antagonist, at Virtual Investor Event on Tuesday, Oct. 14
September 29, 2025
From AnaptysBio, Inc.
Via GlobeNewswire
Tickers
ANAB
uniQure Announces Closing of Upsized Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares
September 29, 2025
From uniQure Inc.
Via GlobeNewswire
Tickers
QURE
Progress Software Announces Third Quarter 2025 Financial Results
September 29, 2025
Via GlobeNewswire
Tickers
PRGS
Septerna Appoints Veteran Biotechnology Leader Keith Gottesdiener, M.D., to its Board of Directors
September 29, 2025
From Septerna, Inc.
Via GlobeNewswire
Tickers
SEPN
Silo Pharma Updates Strategic Agreement with Fireblocks to Secure Crypto Treasury Management
September 29, 2025
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers
SILO
Byline Bank Announces Sponsorship of Chicago Blackhawks
September 29, 2025
From Byline Bank
Via GlobeNewswire
Tickers
BY
TechSmith Announces Inaugural TechSmith Unlocked Virtual Conference
September 29, 2025
Via GlobeNewswire
From Brodsky & Smith LLC
From Brodsky & Smith LLC
2025 China (Shenyang) South Korea Week Kicks Off
September 29, 2025
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.